• 1. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 2. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
• 3. An investigation into the origin of variations in photovoltaic performance using D–D–π–A and D–A–π–A triphenylimidazole dyes with a copper electrolyte?
  Govind Reddy Mol. Syst. Des. Eng., 2021,6, 779-789
• 4. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
• 5. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996

Research Briefing on 3-Bromo-5-fluoropicolinamide (CAS: 2089325-14-2) in Chemical Biology and Pharmaceutical Applications

3-Bromo-5-fluoropicolinamide (CAS: 2089325-14-2) has recently emerged as a compound of significant interest in medicinal chemistry and drug discovery. This heterocyclic amide derivative, featuring both bromine and fluorine substituents on its pyridine core, demonstrates unique physicochemical properties that make it a valuable building block for pharmaceutical development. Recent studies have highlighted its potential as a key intermediate in the synthesis of kinase inhibitors and other biologically active molecules.

Structural analyses of 3-Bromo-5-fluoropicolinamide reveal that the bromine atom at the 3-position serves as an excellent handle for further functionalization through cross-coupling reactions, while the fluorine at the 5-position enhances metabolic stability and influences molecular recognition. The amide moiety provides hydrogen bonding capabilities critical for target engagement. These combined features have led to its incorporation in several drug discovery programs targeting protein kinases and other enzyme families.

Recent synthetic methodology developments have demonstrated efficient routes to 3-Bromo-5-fluoropicolinamide through palladium-catalyzed halogenation of fluoropicolinic acid derivatives followed by amidation. A 2023 study published in the Journal of Medicinal Chemistry reported a novel one-pot synthesis with 78% yield, significantly improving upon previous methods. The compound's stability under various reaction conditions has been thoroughly characterized, supporting its utility as a versatile synthetic intermediate.

In biological applications, 3-Bromo-5-fluoropicolinamide has shown promise as a core scaffold for developing selective kinase inhibitors. Research from the University of Cambridge (2024) demonstrated its successful incorporation into potent and selective inhibitors of JAK3 kinase, with the bromine atom enabling crucial hydrophobic interactions in the ATP-binding pocket. The fluorine substitution was shown to reduce off-target effects while maintaining nanomolar potency against the intended target.

Pharmacokinetic studies of derivatives containing the 3-Bromo-5-fluoropicolinamide moiety have revealed favorable drug-like properties, including improved membrane permeability and metabolic stability compared to non-fluorinated analogs. These findings, published in recent issues of Bioorganic & Medicinal Chemistry Letters, suggest that this structural motif may help address common challenges in drug development programs.

Ongoing research is exploring the application of 3-Bromo-5-fluoropicolinamide in PROTAC (proteolysis targeting chimera) development, where its ability to serve as a linker between target-binding and E3 ligase-recruiting moieties is being investigated. Preliminary results indicate that the bromine substitution pattern provides optimal spacing and orientation for effective protein degradation.

Future directions for research on 3-Bromo-5-fluoropicolinamide include expanding its utility in fragment-based drug discovery and exploring its potential in radiopharmaceutical applications, where the bromine atom could serve as a site for radioisotope incorporation. The compound's unique combination of properties positions it as a valuable tool for addressing multiple challenges in modern drug discovery.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)